SCHEDULE 1 THERAPEUTICS INC
Chicago, IL · Biotech · Private
Purified cannabinoid molecules (CBD and THC) formulated as oral therapeutics for migraine treatment
s1therapeutics.com →- Grants
- $3.5M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 17
- 3 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $308,465 | |
| Federal grant | Department of Health and Human Services · Phase I · Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $308,465 | |
| Federal grant | Department of Health and Human Services · Phase II · Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $2,019,222 | |
| Federal grant | Department of Health and Human Services · Phase II · Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $864,417 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3165 | Smart Biomolecules, Inc. | — | — |
| 3166 | IONIC PHARMACEUTICALS, LLC | — | — |
| 3167 | Sitryx Therapeutics | — | — |
| 3168 | SCHEDULE 1 THERAPEUTICS INC | — | — |
| 3169 | CURATIX, LLC | — | — |
| 3170 | Encoded Therapeutics | — | — |
| 3171 | Chimagen Biosciences | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions Comprising Cannabinoids And Methods Of Useapplication
- Use Of Cannabinoid Compositions For Treating Pain Associated With Small Fiber Neuropathyapplication
- Compositions And Methods For Treating Hemiplegic Migraineapplication
- Compositions Comprising Cannabinoids And Methods Of Useapplication
- Compositions Comprising Cannabinoids And Methods Of Useapplication
- Compositions Comprising Cannabinoids And Methods Of Usegranted
- Compositions Comprising Cannabinoids And Methods Of Usegranted
- Compositions Comprising Cannabinoids And Methods Of Usegranted
- Compositions Comprising Cannabinoids And Methods Of Use Thereofapplication
- Compositions Comprising Cannabinoids And Methods Of Use Thereofapplication
- Combined Effects Of Cannabidiol And DELTA-9-TETRAHYDROCANNABINOL Alleviate Migraine-like Symptoms In Miceapplication
- Compositions And Methods For Treating Hemiplegic Migraineapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.